Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Erythropoietin biosimilar - Pooyesh Darou

Next Previous
Drug Profile

Erythropoietin biosimilar - Pooyesh Darou

Latest Information Update: 13 Jul 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pooyesh Darou
  • Class Antianaemics; Erythropoietins
  • Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Solid tumours

Most Recent Events

  • 18 Feb 2022 No development reported - Phase-I/II for Solid tumours in Iran (SC)
  • 16 Oct 2017 Iran University of Medical Sciences, Mashhad University of Medical Sciences, Shiraz University of Medical Sciences, Tabriz University of Medical Sciences and Tehran University of Medical Sciences plan the phase III TONTT-2 trial for traumatic optic neuropathy (In children, In adolescents, In adults) in Iran (IV) (NCT03308448)
  • 23 Jul 2015 Pooyesh Darou completes enrolment in its phase I/II trial for Solid tumours in Iran (IRCT2015061822805N1)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top